SANUWAVE Health, Inc. SNWV

Company Overview

SANUWAVE Health, Inc. is a U.S.-based medical technology company focused on developing and commercializing noninvasive regenerative medicine products that utilize extracorporeal shock wave technology. The company primarily operates in the wound care and tissue regeneration markets, with a concentration on chronic wound healing, diabetic foot ulcers, and other hard-to-heal conditions. Its core commercial platform is the UltraMIST system, an ultrasound-based wound healing therapy device used in hospitals, wound care centers, and long-term care facilities. SANUWAVE also develops shock wave-based technologies intended to stimulate tissue repair and angiogenesis.

The company’s business model is centered on medical device sales, recurring treatment-related revenues, and commercialization partnerships within the healthcare sector. SANUWAVE evolved from earlier shock wave technology development initiatives and has repositioned itself over time toward advanced wound care applications. Public filings and investor materials indicate that the company has increasingly emphasized commercialization and reimbursement-supported clinical adoption within the U.S. healthcare market, particularly following broader acceptance of noncontact low-frequency ultrasound wound therapies.